Cancer Prevention Research · 2016 · 43 citations · 42 references
MedicineOncologyPathologyCytopathologyMolecular DiagnosticsMolecular PathologyCervical CancerCervical CytologyCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyCervicovaginal CytologyBiomarkers Of Cervical LesionsCervical Intraepithelial Neoplasia DiagnosisCervical Lesion TriageCirculating Cell-free Dna AnalysisCirculating Cell-free Dna MethylationMolecular Panel TestingPromoter MethylationTriage Of Abnormal Cytology
Abstract Clinically useful molecular tools to triage women for a biopsy upon referral to colposcopy are not available. We aimed to develop a molecular panel to detect cervical intraepithelial neoplasia (CIN) grade 2 or higher lesions (CIN2+) in women with abnormal cervical cytology and high-risk HPV (HPV+). We tested a biomarker panel in cervical epithelium DNA obtained from 211 women evaluated in a cervical cancer clinic in Chile from 2006 to 2008. Results were verified in a prospective cohort of 107 women evaluated in a high-risk clinic in Puerto Rico from 2013 to 2015. Promoter methylation of ZNF516, FKBP6, and INTS1 discriminated cervical brush samples with CIN2+ lesions from samples with no intraepithelial lesions or malignancy (NILM) with 90% sensitivity, 88.9% specificity, 0.94 area under the curve (AUC), 93.1% positive predictive value (PPV), and 84.2% negative predictive value (NPV). The panel results were verified in liquid-based cervical cytology samples from an independent cohort with 90.9% sensitivity, 60.9% specificity, 0.90 AUC, 52.6% PPV, and 93.3% NPV, after adding HPV16-L1 methylation to the panel. Next-generation sequencing results in HPV+ cultured cells, and urine circulating cell-free DNA (ccfDNA) were used to design assays that show clinical feasibility in a subset (n = 40) of paired plasma (AUC = 0.81) and urine (AUC = 0.86) ccfDNA samples obtained from the prospective cohort. Viral and host DNA methylation panels can be tested in liquid cytology and urine ccfDNA from women referred to colposcopy, to triage CIN2+ lesions for biopsy and inform personalized screening algorithms. Cancer Prev Res; 9(12); 915–24. ©2016 AACR.
42
Fast gapped-read alignment with Bowtie 2
Ben Langmead, Steven L. Salzberg · Nature Methods · 2012 · 61.1K citations
Debbie Saslow, Diane Solomon, Herschel W. Lawson et al. · American Journal of Clinical Pathology · 2012 · 791 citations · Full text
Medicine, Gynecology, Pathology +17